Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tantti Laboratory has developed proprietary macroporous chromatography bead technologies and related biomaterials to optimize the purification of advanced modalities such as viral vectors, nucleic acids, viruses, and large molecule biologics. Their DuloCore® platform combines high throughput membrane performance with monolith-like mass transfer in a bead format. The company’s products are used in downstream bioprocessing to address scalability and efficiency challenges. Clinical results are not applicable as they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tantti Laboratory.